NFE2L2 and chronic obstructive pulmonary disease: As activation of the Nrf2/ARE antioxidant pathway is believed to be an efficient therapeutic strategy for redox-related lung diseases, it will be discussed later in a paragraph titled Antioxidant treatment in COPD (42).